VINC

Vincerx Pharma Inc - Regains Compliance With Nasdaq Listing Rule 5550(a)(2)

时间：2025-02-19 05:04:44 市场： 美股 综合

关联： VINC

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory's Trop2 Antibody Drug Conjugate, Oqy-3258

时间：2025-01-29 21:06:55 市场： 综合 美股

关联： VINC

Vincerx Pharma Inc - Stock to Trade on Split-Adjusted Basis From Jan 28

时间：2025-01-24 05:05:00 市场： 美股

关联： VINC

Vincerx Pharma Inc -May Offer, Sell Common Stock With Gross Sales Price of up to $30 Mln Through Wainwright

时间：2025-01-22 05:31:02 市场： 美股 综合

关联： VINC

Vincerx Pharma Inc - DR. Raquel Izumi Appointed Acting CEO

时间：2024-12-28 05:05:00 市场： 美股 综合

关联： VINC

Vincerx Pharma Inc - Implementing Workforce Reduction and Cost-Control Measures

时间：2024-12-28 05:05:00 市场： 美股 综合

关联： VINC

Vincerx Pharma Enters Into a Binding Term Sheet for a Strategic Merger With Oqory, Inc.

时间：2024-12-28 05:05:00 市场： 美股 综合

关联： VINC

Vincerx Pharma Inc: Ahmed Hamdy, Chairman and CEO Has Stepped Down as CEO but Will Remain as Chairman

时间：2024-12-28 05:05:00 市场： 美股 综合

关联： VINC

Vincerx Pharma Inc - Alexander Seelenberger Steps Down as CFO, Kevin Hass Appointed Acting CFO

时间：2024-12-28 05:05:00 市场： 美股 综合

关联： VINC

Vincerx Pharma Inc: to Streamline Operations and Focus Resources, Vincerx Will Implement a Significant Reduction in Force of Approximately 55%

时间：2024-12-04 19:45:05 市场： 综合 美股

关联： VINC